100 in stock
A dual-peptide combination studied for its role in growth hormone signaling pathways.
Overview CJC-1295 (no DAC) is a synthetic analog of growth hormone-releasing hormone (GHRH), while Ipamorelin is a selective growth hormone secretagogue. Together, they are studied for their synergistic effects on pulsatile growth hormone release and endocrine signaling.
Research has explored their combined activity in relation to sleep cycles, recovery pathways, and metabolic regulation.
Specifications Composition: CJC-1295 (No DAC) / Ipamorelin Purity: ≥99% (per component) Form: Lyophilized powder Storage: Store (2–8°C)
$65.00
100 in stock
Independent third-party laboratory testing is currently in progress. Results will be visible here once available.
✓ You are 21 years of age or older
✓ All products are sold strictly for lawful laboratory research
✓ Products are not intended for human or veterinary use
Entry requires confirmation that all materials are acquired solely for lawful scientific, laboratory, analytical, and in-vitro research. Products are supplied strictly as research materials and are not intended for human or veterinary use, administration, diagnosis, treatment, or consumption.